Methods for culturing and identifying nasopharyngeal carcinoma organs
A culture method and organoid technology, applied in the field of culture medium for nasopharyngeal carcinoma organoids, can solve the problems of unfavorable research, unfavorable nasopharyngeal carcinoma tissue culture, differences between primary cells and patient-derived parental nasopharyngeal carcinoma tissues, etc., and achieve High consistency, with consistent effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0046] A culture medium for nasopharyngeal carcinoma organoids, the medium comprising the following components: B27, 50X dilution; N-acetylcysteine 1mM; EGF 5ng / ml; Noggin 100ng / ml, R-spondin 1 250ng / ml; A83-01500nM ; HGF 10ng / ml; Nicotinamide 10mM; Y-27632 10μM; Wnt3a 250ng / ml; Glutmax 100X dilution; Heregulinβ-1 20ng / ml; 10ng / ml.
Embodiment 2
[0048] According to the method for culturing nasopharyngeal carcinoma organoids in the culture medium of Example 1, the specific method is as follows:
[0049] Shred the tumor tissue on ice, add organoid digestive enzyme I to resuspend, transfer to 37°C, 220rpm constant temperature shaker for digestion for about 1.5 hours; after the first digestion, centrifuge to discard the supernatant, add 2ml digestive enzyme II to pipette Resuspend, place the centrifuge tube in a 37°C, 220rpm constant temperature shaker for 10 minutes, add Hanks solution to stop the digestion, after digestion with digestive enzyme II, single cells are obtained; after the second digestion, discard the supernatant by centrifugation to obtain cell pellets, Add 2ml of Hanks solution to resuspend the digested tissue pellet; filter the cells with a 70μm cell mesh, and centrifuge to discard the supernatant; take 1ml of red blood cell lysate to resuspend the cells for 2-3min, then add 1ml of HBSS to terminate; then...
Embodiment 3
[0052] The organoids cultivated in Example 2 were identified, and the specific identification methods were as follows:
[0053] The organoids were collected, dropped into the OCT embedding medium prepared in advance, frozen at -80°C and sectioned (stained routinely), and the cell type and cell source were identified. Immunofluorescent staining and Q-PCR were used to detect the expression of genes related to nasopharyngeal mucosa tissue derived from cells in the tissue. Organoids, tumor tissues and blood from patients were sent to BGI for full tumor exome and Epstein-Barr virus gene sequencing, which confirmed the homology between tumor tissues and nasopharyngeal carcinoma organoids. Using CRISPR / Cas9 technology to mutate genes in vitro to study the role of related genes in the occurrence and development of nasopharyngeal carcinoma-related diseases.
[0054] The specific steps of homology and stability identification are as follows:
[0055] (1) Whole exome sequencing of naso...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com